Jan. 14, 2025 /Mpelembe Media/ — BAIBYS™, an Israeli startup, announced its CE-marked AI-powered robotic system for autonomous sperm selection in IVF. This system uses AI and machine vision to identify and isolate optimal sperm cells, addressing the growing global issue of male infertility. Continue reading
Jan. 14, 2025 /Mpelembe Media/ — A Boldyn Networks study highlights the increasing importance of robust Wi-Fi and cellular connectivity in commercial real estate. This surpasses price and amenities as a key factor for businesses choosing office space, with a significant majority willing to pay more for reliable connectivity. Continue reading
Jan. 11, 2025 /Mpelembe Media/ — nsave, a fintech company founded by former Rhodes Scholars, launched an investment platform offering safe, compliant overseas accounts and investments to individuals in high-inflation economies. This platform provides access to US equities, ETFs, and soon, funds, aiming to protect and grow wealth for those facing financial exclusion. Continue reading
Jan. 6, 2025 /Mpelembe Media/ — , a medical technology company, is partnering with the Mayo Clinic to pilot its Nevisense device in the US. Nevisense, an FDA-approved AI-powered tool, aids in the early detection of melanoma, the deadliest form of skin cancer. Continue reading
Jan. 4, 2025 /Mpelembe Media/ — Christian Aid’s report, “Counting the Cost 2024,” analyses the economic impact of ten extreme weather events in 2024, revealing billions of dollars in losses and highlighting the disproportionate effect on poorer nations. The report underscores the urgent need to reduce carbon emissions and transition to renewable energy, citing expert opinions stressing the escalating consequences of inaction. Continue reading
Jan. 3, 2025 /Mpelembe Media/ — The Surgeon General of the U.S. has called for cancer warnings on alcoholic beverages, citing studies linking alcohol consumption to at least seven types of cancer. A recent review of research supports this, showing a correlation between higher alcohol intake and increased cancer risk, particularly breast cancer. Continue reading
Jan. 3, 2025 /Mpelembe Media/ — Oncolytics Biotech Inc.’s progress in developing cutting-edge immunotherapies for cancer treatment is the article’s main subject. The piece highlights several key advancements, including clinical trial results and collaborations with other companies. Financial information regarding Oncolytics is included, along with a disclaimer about the nature of the publication. Continue reading
Jan. 1, 2025 /Mpelembe Media/ — The Wine Market Journal released its annual list of top-appreciating wines for 2024, highlighting eleven wines that significantly outperformed the stock market. Analysis considered auction data from 2023 and 2024, focusing on wines with sufficient trade volume and minimum average prices. The list showcased various wines, including several from the 1970s, reflecting trends in collector preferences for older vintages and specific regions. Continue reading
Jan. 1, 2025 /Mpelembe Media/ — Patricia Green Rodgers’ article details her journey from aspiring artist to social entrepreneur, highlighting the pivotal role her artistic background played in shaping her career and her focus on empowering women. Here’s a summary of the key takeaways: Continue reading
Craig Robertson, University of Oxford
When Elon Musk took over Twitter and changed its name to X, many users vowed to move to another platform. First was talk of a shift to Mastodon that never seemed to catch on. Then Meta tried to make Threads appealing by linking the app to Instagram – but this hasn’t had much cut-through either.